Article Text

PDF
Original article
Survival of Australian lung cancer patients and the impact of distance from and attendance at a thoracic specialist centre: a data linkage study
  1. Elizabeth Tracey1,
  2. Brian McCaughan2,
  3. Tim Badgery-Parker1,
  4. Jane Young1,
  5. Bruce Armstrong1
  1. 1University of Sydney, Sydney, New South Wales, Australia
  2. 2Royal Prince Alfred Hospital, Sydney, New South Wales, Australia
  1. Correspondence to Elizabeth Tracey, The University of Sydney, Level 6 Chris O'Brien Lifehouse (C39Z), 119–143 Missenden Road, Camperdown, NSW 2050, Australia; elizabeth.tracey{at}sydney.edu.au

Abstract

Background Lung cancer patients have better survival when treated in thoracic surgical (specialist) centres.

Aims To determine whether outcome of non-small cell lung cancer (NSCLC) patients is poorer with increasing distance to the nearest accessible specialist hospital (NASH).

Methods We linked cancer registry, hospital and death records of 23 871 NSCLC patients; 3240 localised, 2435 regional and 3540 distant stage patients hospitalised within 12 months of diagnosis were analysed. Distance from patients’ residences to the NASH was measured using geographical coordinates. Cox proportional hazards models examined predictors of NSCLC death.

Results Having a resection of the cancer, which admission to a specialist hospital made more likely, substantially reduced hazard of NSCLC death. Distance influenced hazard of death through both these variables; a patient was less likely to be admitted to a specialist hospital than a general hospital and less likely to have a resection the further they lived from the NASH. However, patients who lived distant from the NASH and were admitted to a specialist hospital were more likely to have a resection and less likely to die from NSCLC than patients admitted to a specialist hospital and living closer to the NASH. These patterns varied little with lung cancer stage.

Conclusions NSCLC outcome is best when patients are treated in a specialist hospital. Greater distance to the NASH can affect its outcome by reducing the likelihood of being treated in a specialist hospital. Research is needed into patient and health service barriers to referral of NSCLC patients for specialist care.

  • Non-Small Cell Lung Cancer
  • Thoracic Surgery
  • Clinical Epidemiology

Statistics from Altmetric.com

Request permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.

Linked Articles